ONS - Oncobiologics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. Estimate-0.23-0.23-0.93-0.73
Low Estimate-0.23-0.23-0.93-0.73
High Estimate-0.23-0.23-0.93-0.73
Year Ago EPS-0.34-0.22-1.67-0.93
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts0011
Avg. EstimateN/AN/A4M19M
Low EstimateN/AN/A4M19M
High EstimateN/AN/A4M19M
Year Ago SalesN/AN/A3.81M4M
Sales Growth (year/est)N/AN/A4.90%375.00%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.49-0.64-0.62-0.24
EPS Actual-0.34-0.22-0.31-0.31
Difference0.150.420.31-0.07
Surprise %30.60%65.60%50.00%-29.20%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.23-0.23-0.93-0.73
7 Days Ago-0.23-0.23-0.93-0.73
30 Days Ago-0.23-0.23-0.93-0.73
60 Days Ago-0.23-0.23-0.93-0.73
90 Days Ago-0.85-0.9-3.551.13
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesONSIndustrySectorS&P 500
Current Qtr.32.40%N/AN/A0.42
Next Qtr.-4.50%N/AN/A0.38
Current Year44.30%N/AN/A0.20
Next Year21.50%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A